Andrew I. Koven - Jun 15, 2025 Form 4 Insider Report for KALA BIO, Inc. (KALA)

Role
Director
Signature
/s/ Mary Reumuth, Attorney-in-Fact
Stock symbol
KALA
Transactions as of
Jun 15, 2025
Transactions value $
$0
Form type
4
Date filed
6/17/2025, 08:00 PM
Previous filing
Jun 12, 2024
Next filing
Jul 1, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KOVEN ANDREW I Director C/O KALA BIO, INC., 1167 MASSACHUSETTS AVENUE, ARLINGTON /s/ Mary Reumuth, Attorney-in-Fact 2025-06-17 0001258673

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KALA Common Stock Award $0 +3.05K +21.91% $0.00 17K Jun 15, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KALA Stock Option (right to buy) Award $0 +6.85K $0.00 6.85K Jun 15, 2025 Common Stock 6.85K $4.30 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units ("RSUs") under the Issuer's Amended and Restated 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service, the RSUs will vest as to 100% of the shares underlying the grant on the earlier of (i) June 15, 2026 or (ii) the date of the first annual meeting of stockholders occurring in 2026.
F2 Includes 8,061 unvested RSUs.
F3 This option was granted on June 15, 2025 and vests as to 100% of the shares underlying the grant on the earlier of (i) June 15, 2026 or (ii) the date of the first annual meeting of stockholders occurring in 2026.